Amarin to slash jobs as generic rivals dull U.S. prospects of heart drug
(Reuters) -Amarin Corp Plc said on Monday it would cut its workforce by 40%, as the drugmaker’s fish-oil derived heart drug faces stiff competition from generic rivals in the United…